The Use of Botulinum Toxin for the Treatment of Chronic Joint Pain: Clinical and Experimental Evidence

被引:12
作者
Blanshan, Nicole [1 ]
Krug, Hollis [1 ,2 ]
机构
[1] Minneapolis VA Hlth Care Syst, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA
关键词
pain; botulinum toxin; arthritis; osteoarthritis; intra-articular; KNEE OSTEOARTHRITIS; CLOSTRIDIUM-BOTULINUM; ARTHROSCOPIC SURGERY; NEUROTOXIN; ARTHRITIS; METAANALYSIS; INHIBITION; PREVALENCE; ARTHROPLASTY; POTENTIATION;
D O I
10.3390/toxins12050314
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Chronic osteoarthritis pain is an increasing worldwide problem. Treatment for osteoarthritis pain is generally inadequate or fraught with potential toxicities. Botulinum toxins (BoNTs) are potent inhibitors of neuropeptide release. Paralytic toxicity is due to inhibition at the neuromuscular junction, and this effect has been utilized for treatments of painful dystonias. Pain relief following BoNT muscle injection has been noted to be more significant than muscle weakness and hypothesized to occur because of the inhibition of peripheral neuropeptide release and reduction of peripheral sensitization. Because of this observation, BoNT has been studied as an intra-articular (IA) analgesic for chronic joint pain. In clinical trials, BoNT appears to be effective for nociceptive joint pain. No toxicity has been reported. In preclinical models of joint pain, BoNT is similarly effective. Examination of the dorsal root ganglion (DRG) and the central nervous system has shown that catalytically active BoNT is retrogradely transported by neurons and then transcytosed to afferent synapses in the brain. This suggests that pain relief may also be due to the central effects of the drug. In summary, BoNT appears to be safe and effective for the treatment of chronic joint pain. The long-term effects of IA BoNT are still being determined.
引用
收藏
页数:13
相关论文
共 68 条
  • [1] Transsynaptic inhibition of spinal transmission by A2 botulinum toxin
    Akaike, Norio
    Shin, Min-Chul
    Wakita, Masahito
    Torii, Yasushi
    Harakawa, Tetsuhiro
    Ginnaga, Akihiro
    Kato, Keiko
    Kaji, Ryuji
    Kozaki, Shunji
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2013, 591 (04): : 1031 - 1043
  • [2] Clinical benefit of intra-articular saline as a comparator in clinical trials of knee osteoarthritis treatments: A systematic review and meta-analysis of randomized trials
    Altman, Roy D.
    Devji, Tahira
    Bhandari, Mohit
    Fierlinger, Anke
    Niazi, Faizan
    Christensen, Robin
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2016, 46 (02) : 151 - 159
  • [3] Anderson Stephanie, 2010, J Pain Res, V3, P161, DOI 10.2147/JPR.S12520
  • [4] Long-distance retrograde effects of botulinum neurotoxin A
    Antonucci, Flavia
    Rossi, Chiara
    Gianfranceschi, Laura
    Rossetto, Ornella
    Caleo, Matteo
    [J]. JOURNAL OF NEUROSCIENCE, 2008, 28 (14) : 3689 - 3696
  • [5] Intra-articular onabotulinumtoxinA in osteoarthritis knee pain: effect on human mechanistic pain biomarkers and clinical pain
    Arendt-Nielsen, L.
    Jiang, G-L
    DeGryse, R.
    Turkel, C. C.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2017, 46 (04) : 303 - 316
  • [6] EFFECT OF THERAPEUTIC EXERCISE ON KNEE OSTEOARTHRITIS AFTER INTRAARTICULAR INJECTION OF BOTULINUM TOXIN TYPE A, HYALURONATE OR SALINE: A RANDOMIZED CONTROLLED TRIAL
    Bao, Xiao
    Tan, Jie-Wen
    Flyzik, Michael
    Ma, Xian-Cong
    Liu, Howe
    Liu, Hui-Yu
    [J]. JOURNAL OF REHABILITATION MEDICINE, 2018, 50 (06) : 534 - 541
  • [7] A Novel Strain of Clostridium botulinum That Produces Type B and Type H Botulinum Toxins
    Barash, Jason R.
    Arnon, Stephen S.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (02) : 183 - 191
  • [8] The analgesic effect of intraarticular OnabotulinumtoxinA in a female murine model of collagenase induced chronic degenerative monoarthritis
    Blanshan, Nicole
    Mahowald, Maren L.
    Dorman, Christopher
    Frizelle, Sandra
    Krug, Hollis E.
    [J]. TOXICON, 2019, 158 : 8 - 15
  • [9] Efficacy of Intra-Articular Botulinum Toxin Type A in Painful Knee Osteoarthritis: A Pilot Study
    Boon, Andrea J.
    Smith, Jay
    Dahm, Diane L.
    Sorenson, Eric J.
    Larson, Dirk R.
    Fitz-Gibbon, Patrick D.
    Dykstra, Dennis D.
    Singh, Jasvinder A.
    [J]. PM&R, 2010, 2 (04) : 268 - 276
  • [10] SNARE proteins are essential in the potentiation of NMDA receptors by group II metabotropic glutamate receptors
    Cheng, Jia
    Liu, Wenhua
    Duffney, Lara J.
    Yan, Zhen
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2013, 591 (16): : 3935 - 3947